Compound Detail
CHEMBL536151
IMD-0354 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL536151 |
| Name | IMD-0354 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | CHILCFMQWMQVAL-UHFFFAOYSA-N |
23
Targets
29
Activities
3
Assay Types
0
PK Parameters
20
Publications
2
Known Names
1
Mechanisms
Molecular Properties
383.7
MW (Da)
5.34
ALogP
2
HBA
2
HBD
49.3
PSA (Ų)
0.69
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor | INHIBITOR | Inhibitor of nuclear factor kappa-B kinase subunit beta | ✓ | ✓ |
Activity Summary
IC50 25 meas. best 7.8
Kd 2 meas. best 5.83
Ki 2 meas. best 6.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Toxoplasma gondii CHEMBL612888 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| P2X purinoceptor 1 CHEMBL2094 | IC50 | 7.72 | 6.1825 | 19.2 | 4 |
| Human adenovirus 5 CHEMBL612237 | IC50 | 7.22 | 7.22 | 60.0 | 1 |
| P2X purinoceptor 4 CHEMBL2104 | IC50 | 6.81 | 6.81 | 156.0 | 1 |
| HL-60 CHEMBL383 | IC50 | 6.8 | 6.8 | 160.0 | 1 |
| P2X purinoceptor 7 CHEMBL4805 | IC50 | 6.76 | 6.76 | 175.0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta CHEMBL1991 | IC50 | 6.66 | 6.66 | 218.0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha CHEMBL3476 | IC50 | 6.6 | 6.6 | 250.0 | 1 |
| Jurkat CHEMBL397 | IC50 | 6.32 | 6.32 | 480.0 | 1 |
| KG-1 CHEMBL612264 | IC50 | 6.3 | 6.3 | 500.0 | 1 |
| NALM-6 CHEMBL614187 | IC50 | 6.2 | 6.2 | 630.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 6.19 | 6.13 | 640.0 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | Ki | 6.1 | 6.1 | 794.3 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.92 | 5.91 | 1200.0 | 2 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.89 | 5.87 | 1300.0 | 2 |
| Mitogen-activated protein kinase kinase kinase kinase 5 CHEMBL4852 | Kd | 5.83 | 5.83 | 1464.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | Ki | 5.5 | 5.5 | 3162.3 | 1 |
| Myosin light chain kinase, smooth muscle CHEMBL2428 | Kd | 5.49 | 5.49 | 3224.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 5.28 | 5.28 | 5200.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.99 | 4.99 | 10190.0 | 1 |
| Transmembrane protease serine 4 CHEMBL2331048 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
| MG-63 CHEMBL614347 | IC50 | 4.31 | 4.31 | 48720.0 | 1 |
| U2OS CHEMBL615023 | IC50 | 4.29 | 4.29 | 50910.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine